Neurosense Therapeutics Ltd
NRSN1.260USD
+0.180+16.67%
收盤 08/04, 16:00（美東）報價延遲15分鐘
29.27M總市值
虧損本益比TTM
關於 Neurosense Therapeutics Ltd 公司
NeuroSense Therapeutics Ltd 是一家位於以色列的臨牀階段製藥公司。該公司活躍於藥物開發和治療領域，爲肌萎縮側索硬化症 (ALS) 患者以及其他神經退行性疾病提供藥物。該公司的主要候選產品 PrimeC 是一種由特定比例的藥物組成的固定劑量組合口服制劑。除了 PrimeC 之外，該公司還啓動了阿爾茨海默病和帕金森病的研究和開發工作
公司簡介
公司代碼NRSN
公司名稱Neurosense Therapeutics Ltd
上市日期Dec 09, 2021
CEOMr. Alon Ben-Noon
員工數量15
證券類型Ordinary Share
年結日Dec 09
公司地址11 Hamenofim St.
城市HERZLIYA
上市交易所NASDAQ Capital Market Consolidated
國家Israel
郵編4672562
電話97299531142
網址https://www.neurosense-tx.com/
公司代碼NRSN
上市日期Dec 09, 2021
CEOMr. Alon Ben-Noon
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
3.18M
+3.04%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
480.92K
+4.55%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
189.62K
+54.22%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
64.00K
--
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
24.00K
--
Dr. Revital Mandil-Levin, Ph.D.
Dr. Revital Mandil-Levin, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Caren Deardorf
Ms. Caren Deardorf
Non-Executive Independent Director
Non-Executive Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
3.18M
+3.04%
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
480.92K
+4.55%
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
189.62K
+54.22%
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
64.00K
--
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
24.00K
--
Dr. Revital Mandil-Levin, Ph.D.
Dr. Revital Mandil-Levin, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月16日 週五
更新時間: 5月16日 週五
持股股東
股東類型
持股股東
持股股東
佔比
Ben-Noon (Alon)
13.24%
Rimon Gold Assets Ltd
9.60%
Gordon Ariel S
4.31%
Eisenberg (Or)
2.00%
Tracik (Ferenc)
0.79%
Other
70.05%
持股股東
持股股東
佔比
Ben-Noon (Alon)
13.24%
Rimon Gold Assets Ltd
9.60%
Gordon Ariel S
4.31%
Eisenberg (Or)
2.00%
Tracik (Ferenc)
0.79%
Other
70.05%
股東類型
持股股東
佔比
Individual Investor
21.38%
Corporation
9.60%
Investment Advisor
0.29%
Research Firm
0.21%
Venture Capital
0.14%
Hedge Fund
0.11%
Investment Advisor/Hedge Fund
0.07%
Other
68.21%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
37
7.63M
31.79%
+136.65K
2025Q1
39
7.45M
37.28%
+353.50K
2024Q4
38
7.90M
34.02%
+1.29M
2024Q3
32
5.18M
22.45%
-1.31M
2024Q2
35
6.62M
30.57%
+1.57M
2024Q1
38
5.18M
33.20%
-953.28K
2023Q4
38
5.12M
32.81%
-1.05M
2023Q3
33
5.76M
47.99%
-945.27K
2023Q2
33
6.46M
53.11%
+1.06M
2023Q1
30
5.11M
43.34%
-185.85K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Ben-Noon (Alon)
3.18M
13.24%
+93.67K
+3.04%
Apr 07, 2025
Rimon Gold Assets Ltd
2.30M
9.6%
+2.30M
--
Dec 02, 2024
Gordon Ariel S
1.03M
4.31%
+1.30K
+0.13%
Dec 31, 2023
Eisenberg (Or)
480.92K
2%
+20.92K
+4.55%
Apr 07, 2025
Tracik (Ferenc)
189.62K
0.79%
+66.67K
+54.22%
Apr 07, 2025
Russek-Blum (Niva)
75.43K
0.31%
+10.00K
+15.28%
Apr 07, 2025
Leuchtenberger (Mark W)
64.00K
0.27%
--
--
Apr 07, 2025
Morgan Stanley & Co. LLC
50.50K
0.21%
-52.08K
-50.77%
Mar 31, 2025
Meitav Dash Investments Ltd.
40.00K
0.17%
--
--
Mar 31, 2025
XTX Markets LLC
33.71K
0.14%
-8.19K
-19.55%
Mar 31, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
